UroGen (URGN) 2025 Earnings: What Investors Should Know
As UroGen prepares to report 2025 results, investors weigh Jelmyto sales, pipeline progress, and balance-sheet health...
Understanding when it’s too late to start retirement planning is crucial for your financial health. Take action to secure your future now.
19,348 articlesAs UroGen prepares to report 2025 results, investors weigh Jelmyto sales, pipeline progress, and balance-sheet health...
Blend unveils Autopilot AI, a new agent aimed at shaving weeks off mortgage origination. The tool automates document ...
February was brutal for some software names. This piece breaks down why monday.com stock lost february, what that sig...
A contrarian, anti-ESG energy ETF seeks to profit from oil-price volatility by concentrating on top fossil-fuel produ...
Tariffs and policy shifts can ripple through energy markets in surprising ways. This guide breaks down the three esse...
A fresh look at the best brokers march 2026, highlighting ETF access, pricing, and user-friendly tools across leading...
Turning Point Brands stock took a sharp drop this week as investors weighed a disappointing quarter and cautious guid...
Marvell Technology defied earlier sell-offs tied to fears of losing Amazon and Microsoft to rivals, reporting strong ...
A top Nomura strategist says equities are priced for chaos, but the odds of a sweeping market crash remain low as dat...
Walmart and Costco sit at opposite ends of the discount retail universe, yet both deserve a spot on a thoughtful inve...
A breakthrough announcement from OpenAI reshapes AI investing around Amazon. Learn what happened, why it matters, and...
Minnesota’s business elite issued a restrained message on immigration enforcement that drew sharp critique and raised...